![](/img/cover-not-exists.png)
MEDI0382, a GLP-1-glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomised, phase 1 study
Ambery, Philip D., Klammt, Sebastian, Posch, Maximillian G., Petrone, Marcella, Pu, Wenji, Rondinone, Cristina, Jermutus, Lutz, Hirshberg, BoazLanguage:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.13688
Date:
June, 2018
File:
PDF, 524 KB
english, 2018